Cardinal Health Inc (CAH) : Pensionfund Sabic added new position in Cardinal Health Inc during the most recent quarter end. The investment management firm now holds 22,000 shares of Cardinal Health Inc which is valued at $1.8 Million according to a report filed by the company on Apr 4, 2016 with the SEC.Cardinal Health Inc makes up approximately 0.55% of Pensionfund Sabic’s portfolio.
Other Hedge Funds, Including , Pensionfund Dsm Netherlands added CAH to its portfolio by purchasing 48,000 company shares during the most recent quarter which is valued at $3.9 Million. Cardinal Health Inc makes up approx 0.54% of Pensionfund Dsm Netherlands’s portfolio.
On the company’s financial health, Cardinal Health Inc reported $1.30 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Feb 1, 2016. Analyst had a consensus of $1.26. The company had revenue of $31445.00 million for the quarter, compared to analysts expectations of $29227.04 million. The company’s revenue was up 23.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.20 EPS.
Many Wall Street Analysts have commented on Cardinal Health Inc. Cardinal Health Inc was Initiated by Credit Suisse to “Outperform” on Mar 16, 2016. Shares were Reiterated by RBC Capital Mkts on Feb 11, 2016 to “Outperform” and Lowered the Price Target to $ 95 from a previous price target of $105 .Cardinal Health Inc was Downgraded by Raymond James to ” Mkt Perform” on Jan 6, 2016.
Cardinal Health Inc closed down -0.8 points or -0.96% at $82.2 with 11,85,759 shares getting traded on Monday. Post opening the session at $83.11, the shares hit an intraday low of $82.01 and an intraday high of $83.265 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.
Cardinal Health Inc. is a healthcare services and products company. The Company operates in two segments: Pharmaceutical and Medical. The Company also provides medical products to patients in the home. In the United States the Company’s Pharmaceutical segment distributes branded and generic pharmaceutical over-the-counter healthcare and consumer products through its Pharmaceutical Distribution division to retailers hospitals and other healthcare providers. In China the Pharmaceutical segment distributes branded generic and specialty pharmaceutical over-the-counter healthcare and consumer products provides logistics marketing and other services and operates direct-to-patient specialty pharmacies through Cardinal Health China. The Medical segment distributes a range of medical surgical and laboratory products and provides services to hospitals ambulatory surgery centers clinical laboratories and other healthcare providers.